FACT Accreditation of Immune Effector Cellular Therapy Programs
It has been one year since FACT published the FACT Standards for Immune Effector Cells, and the associated accreditation program has not only begun, but has grown and matured over the past several months. Much of its success is credited to the organizations that have undergone inspections and provided important feedback and experience to FACT inspectors and committees.
As of February 12, 2018, 43 inspections of immune effector cellular (IEC) therapy programs have been conducted or scheduled. Of these, 24 have achieved accreditation. Congratulations to all of these programs. It has been an honor for FACT to assist programs with establishing and improving quality-based processes to facilitate desirable outcomes for patients receiving these new therapies.
Clinical Programs Accredited for Immune Effector Cellular Therapy as of February 12, 2018
Banner MD Anderson Cancer Center, Gilbert, AZ
Director: Rajneesh Nath, MD
Baylor College of Medicine, Stem Cell Transplant Program, Texas Children’s Hospital and Houston Methodist Hospital, Houston, Texas
Director: Helen Heslop, MD
Baylor University Medical Center, Dallas, Texas
Director: Edward Agura, MD
Blood and Marrow Transplant Program at Children’s Hospital Los Angeles, Los Angeles, California
Director: Neena Kapoor, MD
Children’s Healthcare of Atlanta Blood and Marrow Transplantation Program, Atlanta, Georgia
Director: Lakshmanan Krishnamurti, MD
Children’s National Health System Blood and Marrow Transplant Program, District of Columbia, Washington
Director: David Jacobsohn, MD, ScM
City of Hope Hematopoietic Cell Transplantation Program, Duarte, California
Director: Stephen J. Forman, MD
Colorado Blood Cancer Institute Blood and Marrow Transplant Program, Denver, Colorado
Director: Richard A. Nash, MD
Emory University Hospital Bone Marrow and Stem Cell Transplant Center, Atlanta, Georgia
Director: Amelia Langston, MD
Hamilton Health Sciences Stem Cell and Bone Marrow Transplant Program, Hamilton, Ontario
Director: Irwin Walker, MBBS, FRACP, FRCPC
Indiana Blood and Marrow Transplantation (IBMT), Indianapolis, Indiana
Director: Luke Akard, MD
Indiana University Bone Marrow and Stem Cell Transplantation Program, Indianapolis, Indiana
Director: Sherif Farag, MD, PhD, FRACP, FRCPA
Mayo Clinic Rochester Blood and Marrow Transplant Program, Rochester, Minnesota
Director: William J. Hogan, MBBCh
Medical College of Wisconsin Blood and Marrow Transplant Program Children’s Hospital of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin
Director: David Margolis, MD, MS
MedStar Georgetown University Hospital Stem Cell Transplant and Cellular Immunotherapy Program, Washington, District of Columbia
Director: Scott Rowley, MD, FACP
Northwell Health Adult HPC Transplant Program, Manhasset, New York
Director: Ruthee-Lu Bayer, MD
Roswell Park Cancer Institute Corporation, Buffalo, New York
Director: Philip L. McCarthy Jr., MD
Sarah Cannon Blood and Marrow Transplant Program, Nashville, Tennessee
Director: Carlos Bachier, MD
St. Jude Children’s Research Hospital Department of Bone Marrow Transplantation and Cellular Therapy, Memphis, Tennessee
Director: Brandon Triplett, MD
Texas Transplant Institute at Methodist Hospital, Methodist Children’s Hospital in San Antonio and South Austin Medical Center in Austin, Austin & San Antonio, Texas
Director: Paul Shaughnessy, MD
The Blood & Marrow Transplantation Program of the Holden Comprehensive Cancer Center at the University of Iowa, Iowa City, Iowa
Director: Margarida Silverman, MD
UCSF Medical Center Adult Blood and Marrow Transplant Program, San Francisco, California
Director: Lloyd Damon, MD
University of Nebraska Medical Center/Nebraska Medicine Hematopoietic Cell Transplantation Program, Omaha, Nebraska
Director: Lori Maness, MD
Westchester Medical Center, Cancer Center, Valhalla, New York
Director: Mitchell Cairo, MD
